Sangui Biotech International, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SGBI research report →
Companywww.sanguibiotech.com
Sangui Biotech International, Inc. , through its subsidiary, Sangui BioTech GmbH, develops hemoglobin-based artificial oxygen carriers for use as blood additives, blood volume substitutes, and variant products. The company's artificial oxygen carriers provide oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia, or blood loss, as well as chronic wounds.
- CEO
- Thomas Striepe
- IPO
- 1997
- HQ
- Hamburg, DE
Price Chart
Valuation
- Market Cap
- $41.98K
- P/E
- 0.34
- P/S
- 0.21
- P/B
- -0.14
- EV/EBITDA
- 0.00
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 100.00%
- Op Margin
- 59.96%
- Net Margin
- 60.82%
- ROE
- -41.61%
- ROIC
- -50.25%
Growth & Income
- Revenue
- $133.34K · 43.32%
- Net Income
- $-12,140 · 91.78%
- EPS
- $-0.00 · 85.71%
- Op Income
- $-1,795
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.71
- Avg Volume
- 113.56K
Get TickerSpark's AI analysis on SGBI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 22 | Striepe Thomas | other | 0 |
| Jun 30, 22 | Schmelz Hubertus | other | 0 |
| Oct 13, 21 | Schmelz Hubertus | sell | 1,200,000 |
| Jun 30, 21 | Schmelz Hubertus | other | 0 |
| Jun 30, 21 | Striepe Thomas | other | 0 |
| Jun 30, 20 | Schmelz Hubertus | other | 0 |
| Jun 30, 20 | Striepe Thomas | other | 0 |
| Jun 30, 19 | Schmelz Hubertus | other | 0 |
| Jun 30, 19 | Striepe Thomas | other | 0 |
| Jun 30, 18 | Schmelz Hubertus | other | 0 |
Our SGBI Coverage
We haven't published any research on SGBI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SGBI Report →